Camerlo S, Ligato J, Rosati G, et al. Shedding light on the pathogenesis of splanchnic vein thrombosis. Int J Mol Sci. 2023;24:2262.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sant’Antonio E, Guglielmelli P, Pieri L, et al. Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases. Am J Hematol. 2020;95:156–66.

Article  PubMed  Google Scholar 

Debureaux PE, Cassinat B, Soret-Dulphy J, et al. Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Adv. 2020;4:3708–15.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tremblay D, Vogel AS, Moshier E, et al. Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience. Eur J Haematol. 2020;104:72–3.

Article  PubMed  Google Scholar 

Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:1465–87.

Article  PubMed  CAS  Google Scholar 

Tremblay D, Winters A, Beckman JD, et al. Splanchnic vein thrombosis associated with myeloproliferative neoplasms. Thromb Res. 2022;218:8–16.

Article  PubMed  CAS  Google Scholar 

Durak ZA, Demirci Z, Eşkazan AE. Masked polycythemia vera: diagnostic challenges and clinical implications. Expert Rev Hematol. 2025;19:1–3.

Article  PubMed  Google Scholar 

Smalberg JH, Arends LR, Valla DC, et al. Myeloproliferative neoplasms in Budd–Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921–8.

Article  PubMed  CAS  Google Scholar 

Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013;122:2176–84.

Article  PubMed  CAS  Google Scholar 

How J, Zhou A, Oh ST. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Ther Adv Hematol. 2017;8:107–18.

Article  PubMed  CAS  Google Scholar 

Valeriani E, Di Nisio M, Riva N, et al. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis. Blood. 2021;137:1233–40.

Article  PubMed  CAS  Google Scholar 

Naymagon L, Tremblay D, Zubizarreta N, et al. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv. 2020;4:655–66.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Naymagon L, Tremblay D, Zubizarreta N, et al. Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation. J Thromb Thrombolysis. 2020;50:652–60.

Article  PubMed  CAS  Google Scholar 

Hoekstra J, Bresser EL, Smalberg JH, et al. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms. J Thromb Haemost. 2011;9:2208–14.

Article  PubMed  CAS  Google Scholar 

Finazzi G, De Stefano V, Barbui T. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018. Blood Cancer J. 2018;8:64.

Article  PubMed  PubMed Central  Google Scholar 

Kiladjian JJ, Cassinat B. Myeloproliferative neoplasms and splanchnic vein thrombosis: contemporary diagnostic and therapeutic strategies. Am J Hematol. 2023;98:794–800.

Article  PubMed  CAS  Google Scholar 

Liu A, Naymagon L, Tremblay D. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment considerations and unmet needs. Cancers (Basel). 2022;15:11.

Article  PubMed  PubMed Central  Google Scholar 

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179–202.

Article  Google Scholar 

Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;73:366–413.

Article  PubMed  Google Scholar